1. Goals
Results and Next Steps
Opportunity/Challenge
Confidential and Proprietary — for GNE Internal Use Only
Program Strategy/Execution
H E R 2
F A M I L Y
Innovation
Her2 Franchise Pharmacy Speaker Bureau Pilot: Rationale for
Translation to a BioOncology Pharmacy Speakers Bureau
Tim Zens, Elizabeth Dragolovich, Brent Kiff, Chris Caughman, Krystal Ide
Pharmacists liked the convenience
of pharmacy-specific one-on-one
education, to be held during their
work hours at their location
•• Collaborate with numerous institutional
pharmacists for needs-assessment and
shaping of the speaker bureau design
•• Present findings to Chris Caughman of
Her2 Marketing
•• Work with Chris and Krystal Ide to adapt
to iGenie format using IPAD based FUZE
technology
The strategy, devised collaboratively through
Chris Caughman and Her2 Marketing, was to
use as many pre-existing PRC-approved tools
as possible since time was of the essence.
•• Use PRC-approved materials for slide decks
•• Enlist TLLs to quickly recruit pharmacy
speakers
•• Use FUZE technology from Zelboraf pilot
•• Pilot test two IGenie iPAD programs through
Liz Dragolovich and Tim Zens
•• Initial pilots were well received
•• Pharmacists appreciated pharmacy-specific information delivered by
other respected pharmacist experts
•• Pharmacists liked the flexibility of the iPAD-based format, where they
can ask questions or have speakers repeat information as needed
•• Because of this initial success, the Kadcyla iGenie Speaker Bureau
was approved
•• Command Central was then staffed to accommodate this new tool
and iGenie was launched to the field in May 2013
Next Steps:
•• Programs are currently being set up for Q2 & Q3
•• The team will assess successes and challenges and
promote to other BioOncology brands as a tool to be
applied by other teams during future launches.
P harmacy is becoming increasingly more
important in determining oncology drug use
and incorporation of drug policy in institutions.
Pharmacists’ educational needs are different from
those of physicians. For example, treatment efficacy
must be well understood so meaningful outcomes,
such as PFS and OS, are valued and considered
during the pharmacy’s budget review. In addition,
understanding the MOA of a particular drug helps
the pharmacist predict side effects and provide
specific “watchouts” to care givers.
B ecause pharmacists demand a “deeper dive”
into efficacy and safety issues, we proposed a
pharmacy-specific speaker bureau as a pilot for the
Kadcyla launch to focus on their needs. Our hope
was that we would be able to translate this tool
within BioOncology for each new product launch,
given that the audience remains the constant.
We believed that better understanding of new
drugs means quicker uptake of new product
launches and perhaps, faster patient benefit.
Confidential. For Internal Use Only.
Elizabeth Dragolovich
Timothy Zens
iGENIE
Pharmacist
Introducing…..
Confidential. For Internal Use Only.
Where Did the Idea
Come from?
Confidential. For Internal Use Only.
What is iGENIE?
Confidential. For Internal Use Only.
Why is iGENIE important?
iGENIE Objectives
• To provide pharmacist specific education on the dosing and administration,
efficacy, and safety of Kadcyla during the early phases of Kadcyla launch
• To expand pharmacist awareness of “look a like, sound a like” with Kadcyla
Confidential. For Internal Use Only.
USER TRAINING|iGENIE Pharmacist
TLL/Speaker Training
March 21st or 27th
• Speakers will be trained on the
FUZE technology and deck content
• 1:1 follow up training prior to the first
program (TLL led)
Field Training
March 28th
• Watch for your gcal invitation to the
COS training
• Download the FUZE app to your ipad
prior to training
• Click on the link in your gcal invite to
launch the FUZE meeting on March
Confidential. For Internal Use Only.
Thank you!